NCT07544511

Brief Summary

Purpose of this study: The purpose of this study is to determine the effect of hand massage stimulation techniques on pain, daily menstrual symptoms and nausea and vomiting in primary dysmenorrhea. H1a: Hand massage stimulation techniques reduce pain in primary dysmenorrhea. H1b: Hand massage stimulation techniques reduce daily menstrual symptoms in primary dysmenorrhea. The data were collected from students suffering from primary dysmenorrhea pain studying at İnönü University Faculty of Health Sciences. Seed therapy (su-jok) will be applied by researcher Esra Tan, who has a basic level su-jok therapy certificate.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Sep 2025Sep 2026

Study Start

First participant enrolled

September 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

April 13, 2026

Last Update Submit

April 18, 2026

Conditions

Keywords

dysmenorrheapainmenstrual symptoms

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    Description: VAS is a scale created in the range of 0-10 cm. According to the scale, 0 cm means the pain is not severe at all, and 10 cm means unbearable pain. On the scale, 0-44 mm indicates mild pain, 45-74 mm indicates moderate pain, and 75-100 mm indicates severe pain. Time Frame: At baseline (pre-intervention) and immediately after completion of seed therapy.

    At baseline (pre-intervention) and immediately after completion of seed therapy]

Secondary Outcomes (1)

  • Daily Menstrual Symptom Assessment Scale (DMSA)

    At baseline (pre-intervention) and immediately after completion of seed therapy]

Study Arms (2)

seed therapy ( su-jok)

EXPERIMENTAL

Group that received seed therapy ( su- jok )

Other: seed threrapy (su-jok)

standard maintenance

NO INTERVENTION

group not receiving seed therapy ( su- jok)

Interventions

In hand massage, tiny swellings called "ball conformity" occur on the reflection points of the organs where the complaint occurs on the hands and feet. It is argued that the sensitivity of the relevant point to pressure has a direct correlation with the level of pain in the body part. A rod called a "diagnostic probe" or "diagnostic rod" made of metal, plastic or wood, approximately ten centimeters long, is used to detect the painful point on the hand and foot. After the correct point is detected, various techniques are applied to stimulate these points and ensure the continuation of the energy flow.In this study, the seed massage technique, which does not cause any side effects among the hand massage stimulation methods, requires a basic level certificate for its use, does not require being a health professional, and can be easily applied by anyone, will be used. Seed massage is a method applied by first detecting pain through a probe on the points of the organs reflected on the hand

seed therapy ( su-jok)

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participant who is 18 years or older
  • Participant diagnosed with primary dysmenorrhea by a gynecologist
  • Participant who has had regular menstruation in the last 6 months
  • Participant whose menstrual pain continues for 8-72 hours

You may not qualify if:

  • Participant who is pregnant
  • Participant who has given birth before or has a history of pregnancy
  • Participant using intrauterine or oral contraceptives
  • Participant who is taking any anti-inflammatory, analgesic and psychotherapeutic medication
  • Participant with any history of pelvic pathology or pelvic surgery
  • Participant with any neurological or systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İnönü University Faculty of Health Sciences

Malatya, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

DysmenorrheaPain

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Esra GÜNEY, PhD

    Inonu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Crossover Assignment randomized controlled trial conducted with experimental and control groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
master's student

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 22, 2026

Study Start

September 1, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Research results will be shared

Locations